CD4 and sarcoidosis: An increased expression of interleukin 17A (IL-17A) has been described in patients with sarcoidosis, and IL-17A-positive CD4+ T cells have also been shown to infiltrate sarcoid lung lesions from patients at different stages of disease evolution [80,81].